Cargando…
Recommended respiratory tests are not routinely performed for mucopolysaccharidosis patients
Recommended respiratory tests used as major outcomes in clinical trials for MPS treatment cannot be routinely performed in everyday practice because neurocognitive impairment and motor skill difficulties affect compliance for most MPS patients https://bit.ly/3G4qp8U
Autores principales: | Denamur, Sophie, Touati, Guy, Debelleix, Stéphane, Damaj, Léna, Barth, Magalie, Tardieu, Marine, Gorce, Magali, Broué, Pierre, Lacombe, Didier, Labarthe, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819247/ https://www.ncbi.nlm.nih.gov/pubmed/35141320 http://dx.doi.org/10.1183/23120541.00567-2021 |
Ejemplares similares
-
Consensus recommendations for diagnosis, management and treatment of Fabry disease in paediatric patients
por: Germain, Dominique P., et al.
Publicado: (2019) -
Newborn Screening of Primary Carnitine Deficiency: An Overview of Worldwide Practices and Pitfalls to Define an Algorithm before Expansion of Newborn Screening in France
por: Lefèvre, Charles R., et al.
Publicado: (2023) -
Incidental diagnosis of mucopolysaccharidosis type I in an infant with chronic intestinal pseudoobstruction by exome sequencing
por: Cospain, Auriane, et al.
Publicado: (2020) -
Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type III
por: Ghosh, Arunabha, et al.
Publicado: (2017) -
Mucopolysaccharidosis Type I
por: Kubaski, Francyne, et al.
Publicado: (2020)